AI systems in breast imaging yield near-perfect negative predictive value but increase recall rates compared to radiologists, particularly for intermediate-risk classifications.
Key Details
- 1Study published in AJR compared Transpara v1.7.1 AI (ScreenPoint Medical) to 11 breast radiologists.
- 2Digital mammography cohort: 26,693 exams; DBT cohort: 4,824 exams.
- 3AI classified most cases as low risk but doubled or more the recall rate compared to radiologists (up to 41.8% for digital mammography at intermediate/elevated threshold).
- 4AI and radiologists both achieved NPVs of 99.8–99.9%.
- 5Sensitivity for AI at intermediate/elevated risk threshold: 94% (digital mammography), specificity fell to 58.6%.
- 6Researchers emphasized need for strategies to reduce false-positives, especially in intermediate-risk cases.
Why It Matters
While AI systems can improve workflow efficiency in breast cancer screening by safely excluding negative cases, their tendency to elevate recall rates could lead to unnecessary follow-ups and anxiety. Addressing false-positive rates is critical for successful clinical integration and radiologist workload management.
Source
AuntMinnie
Related News
•HealthExec
Survey Reveals Top 6 Concerns About Healthcare AI for 2026
A new survey highlights six main concerns clinicians and patients have about healthcare AI in 2026, including bias, governance, deskilling, hallucinations, accountability, and source validation.
•AuntMinnie
AI-Based Slab Reconstruction Streamlines Digital Breast Tomosynthesis
AI-driven slab reconstruction in DBT improves workflow efficiency without compromising diagnostic accuracy in breast cancer screening.
•AuntMinnie
AI Model Predicts Dosimetry for Lu-177 PSMA Therapy Using PET/CT
A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.